Clinical Cancer Research Joint Metastasis Research Society-AACR Conference on Metastasis Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

Clinical Cancer Research 13, 1685-1694, March 15, 2007. doi: 10.1158/1078-0432.CCR-06-2330
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baumgart, E.
Right arrow Articles by Summerhayes, I. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baumgart, E.
Right arrow Articles by Summerhayes, I. C.

Human Cancer Biology

Identification and Prognostic Significance of an Epithelial-Mesenchymal Transition Expression Profile in Human Bladder Tumors

Egbert Baumgart2, Michael S. Cohen2, Brasil Silva Neto1,2, Micah A. Jacobs2, Chad Wotkowicz2, Kimberly M. Rieger-Christ1,2, Andreia Biolo4, Ron Zeheb3, Massimo Loda5, John A. Libertino2 and Ian C. Summerhayes1,2

Authors' Affiliations: 1 Cell and Molecular Biology Laboratory, R.E. Wise M.D. Research and Education Institute; Departments of 2 Urology and 3 Pathology, Lahey Clinic, Burlington, Massachusetts; 4 Department of Internal Medicine and Cardiology, Hospital De Clinicas de Porto Alegre, Porto Alegre, Brazil; and 5 Department of Pathology, Dana-Farber Cancer Center, Boston, Massachusetts

Requests for reprints: Ian C. Summerhayes, Cell and Molecular Biology Laboratory, Robert E. Wise M.D. Research and Education Institute, Lahey Clinic, 31 Mall Road, Burlington, MA 01805. Phone: 781-744-2990; Fax: 781-744-2984; E-mail: Ian.C.Summerhayes{at}lahey.org.

Purpose: Epithelial to mesenchymal transition (EMT) is reportedly an important transition in cancer progression in which the underlying cellular changes have been identified mainly using in vitro models. In this study, we examined the expression pattern of EMT markers in vivo and determined the occurrence and clinical significance of these events in a series of bladder carcinomas.

Experimental Design: Eight hundred and twenty-five tumor samples from 572 bladder cancer patients were assembled in 10 tissue microarrays. Paraffin sections from each tissue microarray were subjected to antigen retrieval and processed by immunohistochemistry for the expression of E-cadherin, plakoglobin, ß-catenin, N-cadherin, and vimentin.

Results: Pathologic expression of E-cadherin, ß-catenin, plakoglobin, and vimentin were associated with the clinicopathologic variables of grade and stage with only the cytoplasmic localization of plakoglobin found associated with lymph node status. Associations between the aforementioned markers were found significant as determined by the Spearman correlation coefficient with N-cadherin showing no associations in this analysis. In univariate survival analysis involving patients who underwent cystectomy, the reduction or loss of plakoglobin significantly influenced overall survival (P = 0.02) in which the median time to death was 2 years compared with 4 years when a normal level of plakoglobin was recorded. When the analysis was done for cancer-specific survival, low levels of both plakoglobin (P = 0.02) and ß-catenin (P = 0.02) significantly influenced survival.

Conclusion: The putative markers of EMT defined within a panel of bladder carcinoma cell lines were recorded in vivo, frequently associated with tumors of high grade and stage. Although multivariate analysis showed no significant influence of the EMT biomarkers on survival, alterations associated with plakoglobin were identified as significant prognostic features in these tumors.




This article has been cited by other articles:


Home page
Vet PatholHome page
N. Kobayashi, K. Suzuki, H. Shibuya, T. Sato, I. Aoki, and Y. Nagashima
Renal Collecting Duct Carcinoma in a Dog
Vet. Pathol., July 1, 2008; 45(4): 489 - 494.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. C. Black, G. A. Brown, T. Inamoto, M. Shrader, A. Arora, A. O. Siefker-Radtke, L. Adam, D. Theodorescu, X. Wu, M. F. Munsell, et al.
Sensitivity to Epidermal Growth Factor Receptor Inhibitor Requires E-Cadherin Expression in Urothelial Carcinoma Cells
Clin. Cancer Res., March 1, 2008; 14(5): 1478 - 1486.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2007 by the American Association for Cancer Research.